Amedisys Inc (NASDAQ:AMED) price target raised to $125.00 by Barclays

Analyst Ratings For Amedisys Inc (NASDAQ:AMED)

Story continues below

Today, Barclays raised its price target on Amedisys Inc (NASDAQ:AMED) to $125.00 per share.

There are 7 Hold Ratings, 5 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Amedisys Inc (NASDAQ:AMED) is Hold with a consensus target price of $134.7415 per share, a potential 3.71% upside.

Some recent analyst ratings include

    • On 7/24/2019 Michael Paul North, Insider, sold 10,067 with an average share price of $130.00 per share and the total transaction amounting to $1,308,710.00.
    • On 7/18/2019 Michael Paul North, Insider, sold 1,183 with an average share price of $130.00 per share and the total transaction amounting to $153,790.00.
    • On 6/13/2019 Jake L Netterville, Director, sold 1,863 with an average share price of $118.17 per share and the total transaction amounting to $220,150.71.
    • On 6/10/2019 David L. Kemmerly, Insider, sold 8,125 with an average share price of $117.77 per share and the total transaction amounting to $956,881.25.
    • On 6/10/2019 Jeffrey A Rideout, Director, sold 3,657 with an average share price of $116.03 per share and the total transaction amounting to $424,321.71.
    • On 6/10/2019 Scott G. Ginn, CFO, sold 4,872 with an average share price of $118.50 per share and the total transaction amounting to $577,332.00.
    • On 6/7/2019 Jeffrey A Rideout, Director, sold 1,263 with an average share price of $114.33 per share and the total transaction amounting to $144,398.79.

    About Amedisys Inc (NASDAQ:AMED)
    Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks. Read More…

    Recent Trading Activity for Amedisys Inc (NASDAQ:AMED)
    Shares of Amedisys Inc closed the previous trading session at 130.02 −4.99 3.70% with 292958 shares trading hands.

    An ad to help with our costs